US3272781A
(en)
|
1963-08-07 |
1966-09-13 |
American Potash & Chem Corp |
Boroureas of phosphinoborine polymers
|
FR1425700A
(fr)
|
1965-02-22 |
1966-01-24 |
Basf Ag |
Composés formant des complexes métalliques et procédé pour les préparer et les utiliser
|
US4208328A
(en)
|
1978-04-27 |
1980-06-17 |
General Electric Company |
Alkyl 3,5-dihydroxy-4-(2-benzothiazolyl)benzoates
|
US4789711A
(en)
|
1986-12-02 |
1988-12-06 |
Ciba-Geigy Corporation |
Multifunctional epoxide resins
|
DE3828535A1
(de)
|
1988-08-23 |
1990-03-08 |
Basf Ag |
Benzimidazol-2-carbonsaeureanilide, ihre verwendung als lichtschutzmittel fuer organisches material und mit diesen aniliden stabilisiertes organisches material
|
US5077164A
(en)
|
1989-06-21 |
1991-12-31 |
Minolta Camera Kabushiki Kaisha |
Photosensitive member containing an azo dye
|
DE69421982T2
(de)
|
1993-09-20 |
2000-03-30 |
Fuji Photo Film Co., Ltd. |
Positiv arbeitende Photoresistzusammensetzung
|
JP3461397B2
(ja)
|
1995-01-11 |
2003-10-27 |
富士写真フイルム株式会社 |
ポジ型フオトレジスト組成物
|
JP2001505585A
(ja)
|
1996-12-16 |
2001-04-24 |
藤沢薬品工業株式会社 |
新規アミド化合物およびそれらの一酸化窒素シンターゼ阻害剤としての用途
|
JPH10316853A
(ja)
|
1997-05-15 |
1998-12-02 |
Sumitomo Bakelite Co Ltd |
半導体多層配線用層間絶縁膜樹脂組成物及び該絶縁膜の製造方法
|
WO1999018096A1
(en)
|
1997-10-02 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
WO1999044992A1
(fr)
|
1998-03-05 |
1999-09-10 |
Nissan Chemical Industries, Ltd. |
Composes d'anilide et herbicide
|
JP2000128986A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及びポリベンゾオキサゾール
|
JP2000128984A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及び樹脂
|
JP2000128987A
(ja)
|
1998-10-28 |
2000-05-09 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール前駆体及びポリベンゾオキサゾール
|
US6297351B1
(en)
|
1998-12-17 |
2001-10-02 |
Sumitomo Bakelite Company Limited |
Polybenzoxazole resin and precursor thereof
|
US6867200B1
(en)
|
1998-12-18 |
2005-03-15 |
Axys Pharmaceuticals, Inc. |
(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
|
JP2000212281A
(ja)
|
1999-01-27 |
2000-08-02 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾ―ル前駆体及びポリベンゾオキサゾ―ル樹脂
|
AU6000900A
(en)
|
1999-07-23 |
2001-02-13 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
JP2001114893A
(ja)
|
1999-10-15 |
2001-04-24 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂およびその前駆体
|
US6372907B1
(en)
|
1999-11-03 |
2002-04-16 |
Apptera Corporation |
Water-soluble rhodamine dye peptide conjugates
|
JP2001163975A
(ja)
|
1999-12-03 |
2001-06-19 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂及びその前駆体
|
CN1623984A
(zh)
|
1999-12-27 |
2005-06-08 |
日本烟草产业株式会社 |
稠环化合物及其药物用途
|
WO2001057038A1
(de)
|
2000-02-01 |
2001-08-09 |
Basf Aktiengesellschaft |
Heterozyklische verbindungen und deren anwendung als parp-inhibitoren
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
WO2001074815A2
(en)
|
2000-03-31 |
2001-10-11 |
Ortho Mcneil Pharmaceutical, Inc. |
Phenyl-substituted imidazopyridines
|
AU2001254555A1
(en)
|
2000-04-24 |
2001-11-07 |
Merck Frosst Canada & Co |
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
|
CA2413330A1
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
WO2002014321A1
(en)
|
2000-08-11 |
2002-02-21 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
WO2002048146A2
(de)
|
2000-12-13 |
2002-06-20 |
Basf Aktiengesellschaft |
Verwendung von substituierten imidazoazinen, neue imidazoazine, verfahren zu deren herstellung, sowie sie enthaltende mittel
|
DE60112609T2
(de)
|
2000-12-15 |
2006-01-19 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridine
|
SE0100567D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
JP2004532194A
(ja)
|
2001-03-14 |
2004-10-21 |
エリ リリー アンド カンパニー |
レチノイドxレセプターモジュレータ
|
US7034030B2
(en)
|
2001-03-30 |
2006-04-25 |
Smithkline Beecham Corporation |
Pyralopyridines, process for their preparation and use as therapeutic compounds
|
WO2002083672A1
(en)
|
2001-04-10 |
2002-10-24 |
Smithkline Beecham Corporation |
Antiviral pyrazolopyridine compounds
|
JP2002316966A
(ja)
|
2001-04-19 |
2002-10-31 |
Ueno Seiyaku Oyo Kenkyusho:Kk |
ビナフトール誘導体およびその製法
|
DE60204452T2
(de)
|
2001-04-27 |
2005-12-15 |
Smithkline Beecham Corp. |
Pyrazolo[1,5a]Pyridinderivate
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
JP2005507878A
(ja)
|
2001-09-07 |
2005-03-24 |
スミスクライン ビーチャム コーポレーション |
ヘルペス感染症を治療するためのピラゾロ−ピリジン類
|
TWI320039B
(en)
|
2001-09-21 |
2010-02-01 |
|
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
AU2002334969A1
(en)
|
2001-10-09 |
2003-04-22 |
Sylvie Barchechath |
Use of stat-6 inhibitors as therapeutic agents
|
BR0213208A
(pt)
|
2001-10-09 |
2004-08-31 |
Upjohn Co |
Compostos de tetraidro- e hexaidro-carbazóis de arilsulfonila substituìda, suas composições e usos
|
JP4024579B2
(ja)
|
2002-01-22 |
2007-12-19 |
住友ベークライト株式会社 |
プラスチック光導波路用材料及び光導波路
|
PL373399A1
(en)
|
2002-04-11 |
2005-08-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
BR0309475A
(pt)
|
2002-04-23 |
2005-03-01 |
Shionogi & Co |
Derivados de pirazolo-[1,5-a]-pirimidina e inibidores de nad(p)h oxidase que contêm os mesmos
|
WO2004007472A1
(ja)
|
2002-07-10 |
2004-01-22 |
Ono Pharmaceutical Co., Ltd. |
Ccr4アンタゴニストおよびその医薬用途
|
AU2003249244A1
(en)
|
2002-07-15 |
2004-02-02 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
JP2004059761A
(ja)
|
2002-07-30 |
2004-02-26 |
Sumitomo Bakelite Co Ltd |
ポリベンゾオキサゾール樹脂、その前駆体及びこれらを用いた光導波路材料並びに光導波路
|
JP2004091369A
(ja)
|
2002-08-30 |
2004-03-25 |
Sumitomo Pharmaceut Co Ltd |
新規ビフェニル化合物
|
EP1547996A4
(en)
|
2002-08-30 |
2006-08-02 |
Bf Res Inst Inc |
DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING
|
WO2004033454A1
(en)
|
2002-10-03 |
2004-04-22 |
Smithkline Beecham Corporation |
Therapeutic compounds based on pyrazolopyridine derivatives
|
WO2004035588A1
(en)
|
2002-10-15 |
2004-04-29 |
Smithkline Beecham Corporation |
Pyradazine compounds as gsk-3 inhibitors
|
KR100624406B1
(ko)
|
2002-12-30 |
2006-09-18 |
삼성에스디아이 주식회사 |
비페닐 유도체 및 이를 채용한 유기 전계 발광 소자
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
JP4595288B2
(ja)
|
2003-03-25 |
2010-12-08 |
住友ベークライト株式会社 |
ポリベンゾオキサゾール樹脂、その前駆体及びこれらを用いた光導波路材料並びに光導波路
|
PT1620429E
(pt)
|
2003-04-11 |
2009-04-28 |
Glenmark Pharmaceuticals Sa |
Novos compostos heterocíclicos úteis para o tratamento de perturbações inflamatórias e alérgicas: processo para a sua preparação e composições farmacêuticas que os contêm
|
CA2524048C
(en)
|
2003-05-19 |
2013-06-25 |
Irm Llc |
Immunosuppressant compounds and compositions
|
JP2005002330A
(ja)
|
2003-05-19 |
2005-01-06 |
Sumitomo Electric Ind Ltd |
光学樹脂材料、光学素子、光モジュール、フッ素化ポリマー前駆体及びフッ素化ポリマー
|
US7405295B2
(en)
|
2003-06-04 |
2008-07-29 |
Cgi Pharmaceuticals, Inc. |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
US20060183746A1
(en)
|
2003-06-04 |
2006-08-17 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
WO2005005429A1
(en)
|
2003-06-30 |
2005-01-20 |
Cellular Genomics, Inc. |
Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds
|
WO2005007111A2
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
JP5001650B2
(ja)
|
2003-07-11 |
2012-08-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンズイミダゾールカルボキサミド
|
US20100267778A1
(en)
|
2003-08-04 |
2010-10-21 |
Shinya Kusuda |
Diphenyl ether compound, process for producing the same, and use
|
WO2005014543A1
(ja)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
縮合環化合物及びそのhcvポリメラーゼ阻害剤としての利用
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
AU2004270733B2
(en)
|
2003-09-11 |
2011-05-19 |
Itherx Pharma, Inc. |
Cytokine inhibitors
|
EP1673343A4
(en)
|
2003-10-08 |
2008-09-10 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
JPWO2005040135A1
(ja)
|
2003-10-24 |
2007-03-08 |
小野薬品工業株式会社 |
抗ストレス薬およびその医薬用途
|
WO2005047290A2
(en)
|
2003-11-11 |
2005-05-26 |
Cellular Genomics Inc. |
Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors
|
WO2005063710A1
(de)
|
2003-12-23 |
2005-07-14 |
Basf Aktiengesellschaft |
3-trifluormethylpicolinsäureanilide und ihre verwendung als fungizide
|
AU2005215379A1
(en)
|
2004-02-12 |
2005-09-01 |
Merck & Co., Inc. |
Bipyridyl amides as modulators of metabotropic glutamate receptor-5
|
WO2005077948A1
(ja)
|
2004-02-16 |
2005-08-25 |
Daiichi Pharmaceutical Co., Ltd. |
抗真菌作用複素環化合物
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
JP2005248082A
(ja)
|
2004-03-05 |
2005-09-15 |
Sumitomo Electric Ind Ltd |
ポリベンゾオキサゾール樹脂前駆体の製造方法およびポリベンゾオキサゾール樹脂の製造方法
|
US20050250820A1
(en)
|
2004-03-08 |
2005-11-10 |
Amgen Inc. |
Therapeutic modulation of PPARgamma activity
|
US7432278B2
(en)
|
2004-03-08 |
2008-10-07 |
The University Of North Carolina At Chapel Hill |
Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
|
EP1761496A2
(en)
|
2004-03-31 |
2007-03-14 |
Janssen Pharmaceutica N.V. |
Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
|
JP2005290301A
(ja)
|
2004-04-02 |
2005-10-20 |
Sumitomo Electric Ind Ltd |
ポリベンゾオキサゾール樹脂前駆体の製造方法およびポリベンゾオキサゾール樹脂の製造方法
|
WO2005099656A2
(en)
|
2004-04-06 |
2005-10-27 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
JP4879165B2
(ja)
|
2004-04-20 |
2012-02-22 |
トランス テック ファーマ,インコーポレイテッド |
メラノコルチン受容体の調節因子としての置換チアゾール及びピリミジン誘導体
|
DE102004021716A1
(de)
|
2004-04-30 |
2005-12-01 |
Grünenthal GmbH |
Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
|
WO2005108387A2
(en)
|
2004-05-03 |
2005-11-17 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
TW200626142A
(en)
|
2004-09-21 |
2006-08-01 |
Glaxo Group Ltd |
Chemical compounds
|
US7250441B2
(en)
|
2004-09-23 |
2007-07-31 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
|
US7713973B2
(en)
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
BRPI0517619A
(pt)
|
2004-11-10 |
2008-10-14 |
Cgi Pharmaceuticals Inc |
entidades quìmicas de imidazo[1,2-a] pirazin-8-ilaminas, suas composições farmacêuticas, uso dos referidos compostos na preparação de medicamento, processo de preparação de medicamento e métodos de utilização dos referidos compostos
|
DE102004054665A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
AU2006218403A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
MX2007011041A
(es)
|
2005-03-10 |
2008-02-22 |
Cgi Pharmaceuticals Inc |
Ciertas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas.
|
JP2006290883A
(ja)
|
2005-03-17 |
2006-10-26 |
Nippon Nohyaku Co Ltd |
置換ヘテロ環カルボン酸アニリド誘導体、その中間体及び農園芸用薬剤並びにその使用方法
|
AU2006247118A1
(en)
|
2005-05-20 |
2006-11-23 |
Array Biopharma Inc. |
Raf inhibitor compounds and methods of use thereof
|
US20080220968A1
(en)
|
2005-07-05 |
2008-09-11 |
Ge Healthcare Bio-Sciences Ab |
[1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
|
WO2007034282A2
(en)
|
2005-09-19 |
2007-03-29 |
Pfizer Products Inc. |
Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
CN103936690B
(zh)
|
2005-10-25 |
2016-06-08 |
盐野义制药株式会社 |
氨基二氢噻嗪衍生物
|
JP5249772B2
(ja)
|
2005-11-22 |
2013-07-31 |
メルク・シャープ・アンド・ドーム・コーポレーション |
キナーゼの阻害剤として有用な三環式化合物
|
WO2007067711A2
(en)
|
2005-12-08 |
2007-06-14 |
Amphora Discovery Corporation |
Certain chemical entities, compositions, and methods for modulating trpv1
|
US20090281120A1
(en)
|
2005-12-12 |
2009-11-12 |
Ono Pharmaceutical Co., Ltd |
Bicyclic heterocyclic compound
|
US20090281075A1
(en)
|
2006-02-17 |
2009-11-12 |
Pharmacopeia, Inc. |
Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
JPWO2007102531A1
(ja)
|
2006-03-08 |
2009-07-23 |
武田薬品工業株式会社 |
併用薬
|
MX2008012617A
(es)
|
2006-03-31 |
2008-10-10 |
Novartis Ag |
Compuestos organicos.
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
WO2007146712A2
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008011557A2
(en)
|
2006-07-20 |
2008-01-24 |
Borchardt Allen J |
Heteroaryl inhibitors of rho kinase
|
DE102006035018B4
(de)
|
2006-07-28 |
2009-07-23 |
Novaled Ag |
Oxazol-Triplett-Emitter für OLED-Anwendungen
|
WO2008021745A2
(en)
|
2006-08-16 |
2008-02-21 |
Itherx Pharmaceuticals, Inc. |
Hepatitis c virus entry inhibitors
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法
|
US7563797B2
(en)
|
2006-08-28 |
2009-07-21 |
Forest Laboratories Holding Limited |
Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
|
PE20080839A1
(es)
|
2006-09-11 |
2008-08-23 |
Cgi Pharmaceuticals Inc |
Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
|
PE20081370A1
(es)
|
2006-09-11 |
2008-11-28 |
Cgi Pharmaceuticals Inc |
Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
|
JP2010502751A
(ja)
|
2006-09-11 |
2010-01-28 |
シージーアイ ファーマシューティカルズ,インコーポレイティド |
キナーゼ阻害物質、およびキナーゼ阻害物質の使用および同定方法
|
US7838523B2
(en)
|
2006-09-11 |
2010-11-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
SG174810A1
(en)
|
2006-09-11 |
2011-10-28 |
Matrix Lab Ltd |
Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
|
FR2906250B1
(fr)
|
2006-09-22 |
2008-10-31 |
Sanofi Aventis Sa |
Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
|
CA2667644A1
(en)
|
2006-10-27 |
2008-05-15 |
Wyeth |
Tricyclic compounds as matrix metalloproteinase inhibitors
|
EP2089364B1
(en)
|
2006-11-08 |
2013-06-12 |
Bristol-Myers Squibb Company |
Pyridinone compounds
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
WO2008064317A1
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Lipophilic opioid receptor active compounds
|
WO2008064318A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Peripheral opioid receptor active compounds
|
JP2010513253A
(ja)
*
|
2006-12-14 |
2010-04-30 |
ベーリンガー インゲルハイム インテルナショナール ゲーエムベーハー |
炎症の治療に有用なベンゾオキサゾール類
|
CA2673038C
(en)
|
2006-12-22 |
2015-12-15 |
Incyte Corporation |
Substituted tricyclic heteroaryl compounds as janus kinase inhibitors
|
EP1964840A1
(en)
|
2007-02-28 |
2008-09-03 |
sanofi-aventis |
Imidazo[1,2-a]pyridines and their use as pharmaceuticals
|
US8338437B2
(en)
|
2007-02-28 |
2012-12-25 |
Methylgene Inc. |
Amines as small molecule inhibitors
|
EP1964841A1
(en)
|
2007-02-28 |
2008-09-03 |
sanofi-aventis |
Imidazo[1,2-a]azine and their use as pharmaceuticals
|
JP2008218327A
(ja)
|
2007-03-07 |
2008-09-18 |
Hitachi Ltd |
電解質、電解質膜、それを用いた膜電極接合体、燃料電池電源及び燃料電池電源システム
|
JP2010120852A
(ja)
|
2007-03-09 |
2010-06-03 |
Daiichi Sankyo Co Ltd |
新規なジアミド誘導体
|
JP2010522227A
(ja)
|
2007-03-22 |
2010-07-01 |
アストラゼネカ・アクチエボラーグ |
炎症性疾患の処置のためのキノリン誘導体
|
EP2151435A4
(en)
|
2007-04-24 |
2011-09-14 |
Shionogi & Co |
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
KR20100017255A
(ko)
|
2007-04-24 |
2010-02-16 |
시오노기 앤드 컴파니, 리미티드 |
환식기로 치환된 아미노다이하이드로싸이아진 유도체
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
WO2008141249A1
(en)
|
2007-05-10 |
2008-11-20 |
Acadia Pharmaceuticals Inc. |
Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
|
WO2009027733A1
(en)
|
2007-08-24 |
2009-03-05 |
Astrazeneca Ab |
(2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents
|
CL2008002793A1
(es)
|
2007-09-20 |
2009-09-04 |
Cgi Pharmaceuticals Inc |
Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
|
AU2008302746B2
(en)
|
2007-09-20 |
2014-07-03 |
Amgen Inc. |
1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as SlP receptor modulators for the treatment of immune disorders
|
DE102007048716A1
(de)
|
2007-10-11 |
2009-04-23 |
Merck Patent Gmbh |
Imidazo[1,2-a]pyrimidinderivate
|
TW200932219A
(en)
|
2007-10-24 |
2009-08-01 |
Astellas Pharma Inc |
Oxadiazolidinedione compound
|
CN101910158A
(zh)
*
|
2007-10-25 |
2010-12-08 |
阿斯利康(瑞典)有限公司 |
可用于治疗细胞增殖性病症的吡啶衍生物和吡嗪衍生物
|
US7868001B2
(en)
|
2007-11-02 |
2011-01-11 |
Hutchison Medipharma Enterprises Limited |
Cytokine inhibitors
|
WO2009062059A2
(en)
|
2007-11-08 |
2009-05-14 |
Pharmacopeia, Inc. |
Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
|
EP2231143B1
(en)
|
2007-12-13 |
2013-07-03 |
Merck Sharp & Dohme Corp. |
5H-pyrido[4,3-b]indoles as INHIBITORS OF JANUS KINASES
|
RU2364597C1
(ru)
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
GEP20125588B
(en)
|
2007-12-19 |
2012-07-25 |
Syngenta Participations Ag |
Insecticidal compounds
|
EP2219646A4
(en)
|
2007-12-21 |
2010-12-22 |
Univ Rochester |
METHOD FOR MODIFYING THE LIFETIME OF EUKARYOTIC ORGANISMS
|
EP2231659A4
(en)
|
2007-12-21 |
2011-10-26 |
Univ Sydney |
LIGANDS OF THE TRANSLOCATION PROTEIN
|
PL2233474T3
(pl)
|
2008-01-18 |
2015-12-31 |
Eisai R&D Man Co Ltd |
Skondensowana pochodna aminodihydrotiazyny
|
WO2009096202A1
(ja)
|
2008-01-31 |
2009-08-06 |
Konica Minolta Holdings, Inc. |
ハロ多環芳香族化合物及びその製造方法
|
AU2009218515A1
(en)
|
2008-02-26 |
2009-09-03 |
Novartis Ag |
Heterocyclic compounds as inhibitors of CXCR2
|
EP2095818A1
(en)
|
2008-02-29 |
2009-09-02 |
AEterna Zentaris GmbH |
Use of LHRH antagonists at non-castrating doses
|
FR2928921B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
|
FR2928922B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
|
FR2928924B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
|
JP5432982B2
(ja)
|
2008-03-31 |
2014-03-05 |
武田薬品工業株式会社 |
アポトーシスシグナル調節キナーゼ1阻害剤
|
KR101034351B1
(ko)
*
|
2008-05-14 |
2011-05-16 |
한국화학연구원 |
신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물
|
CA2724842A1
(en)
|
2008-05-19 |
2009-11-26 |
Sunovion Pharmaceuticals Inc. |
Imidazo[1,2-a]pyridine compounds
|
JP2011521960A
(ja)
|
2008-05-29 |
2011-07-28 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
サーチュイン調節薬としてのイミダゾピリジンおよび関連する類似体
|
ES2566339T3
(es)
|
2008-06-05 |
2016-04-12 |
Glaxo Group Limited |
Derivados de 4-carboxamida indazol útiles como inhibidores de PI3-quinasas
|
JP2011529073A
(ja)
|
2008-07-24 |
2011-12-01 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼ調節因子として有用な縮合ヘテロ環化合物
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
US9540322B2
(en)
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
JP2011231017A
(ja)
|
2008-09-09 |
2011-11-17 |
Nissan Chem Ind Ltd |
光学活性エポキシ化合物及び光学活性スルホキシド化合物の製造方法、並びに該方法に用いる配位子、錯体及び該錯体の製造方法
|
WO2010056875A1
(en)
|
2008-11-12 |
2010-05-20 |
Cgi Pharmaceuticals, Inc. |
Pyridazinones and their use as btk inhibitors
|
WO2010064020A1
(en)
|
2008-12-04 |
2010-06-10 |
Proximagen Ltd. |
Imidazopyridine compounds
|
JP5557849B2
(ja)
|
2008-12-19 |
2014-07-23 |
ブリストル−マイヤーズ スクイブ カンパニー |
カルバゾールおよびカルボリンキナーゼ阻害剤
|
TW201035100A
(en)
|
2008-12-19 |
2010-10-01 |
Cephalon Inc |
Pyrrolotriazines as ALK and JAK2 inhibitors
|
CA2747670A1
(en)
|
2008-12-19 |
2010-07-15 |
Bristol-Myers Squibb Company |
Carbazole carboxamide compounds useful as kinase inhibitors
|
JP5624275B2
(ja)
|
2008-12-22 |
2014-11-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
JP2012513409A
(ja)
|
2008-12-23 |
2012-06-14 |
アボット・ラボラトリーズ |
抗ウイルス化合物
|
WO2010074284A1
(ja)
|
2008-12-26 |
2010-07-01 |
味の素株式会社 |
ピラゾロピリミジン化合物
|
JP2010202530A
(ja)
|
2009-02-27 |
2010-09-16 |
Tokyo Institute Of Technology |
含ヘテロ芳香族化合物および光学材料
|
WO2010104307A2
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
CN102574786A
(zh)
|
2009-04-02 |
2012-07-11 |
默克雪兰诺有限公司 |
二氢乳清酸脱氢酶抑制剂
|
DK2419429T3
(da)
|
2009-04-16 |
2014-06-23 |
Ct Nac De Investigaciones Oncológicas Cnio |
Imidazopyraziner som inhibitorer af proteinkinaser
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
JP2012532102A
(ja)
|
2009-06-30 |
2012-12-13 |
シガ・テクノロジーズ・インコーポレーテッド |
デングウイルス感染の治療法および予防法
|
US8993604B2
(en)
|
2009-06-30 |
2015-03-31 |
Siga Technologies, Inc. |
Treatment and prevention of dengue virus infections
|
TWI598347B
(zh)
|
2009-07-13 |
2017-09-11 |
基利科學股份有限公司 |
調節細胞凋亡信號之激酶的抑制劑
|
JP2011057661A
(ja)
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
US9095596B2
(en)
|
2009-10-15 |
2015-08-04 |
Southern Research Institute |
Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such
|
CA2777734A1
(en)
|
2009-10-16 |
2011-04-21 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial compounds and methods of making and using the same
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
WO2011078221A1
(ja)
|
2009-12-24 |
2011-06-30 |
味の素株式会社 |
イミダゾピリダジン化合物
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
AR080433A1
(es)
|
2010-03-02 |
2012-04-11 |
Merck Sharp & Dohme |
Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
|
US9024032B2
(en)
|
2010-03-04 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
|
RU2576662C2
(ru)
|
2010-03-18 |
2016-03-10 |
Энститю Пастер Корея |
Противоинфекционные соединения
|
US8410117B2
(en)
|
2010-03-26 |
2013-04-02 |
Hoffmann-La Roche Inc. |
Imidazopyrimidine derivatives
|
WO2011159857A1
(en)
|
2010-06-16 |
2011-12-22 |
Bristol-Myers Squibb Company |
Carboline carboxamide compounds useful as kinase inhibitors
|
CN102295642B
(zh)
|
2010-06-25 |
2016-04-06 |
中国人民解放军军事医学科学院毒物药物研究所 |
2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
|
EP2402345A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
CN101891895B
(zh)
|
2010-07-28 |
2011-11-30 |
南京航空航天大学 |
基于桥联双水杨醛结构的苯并噻唑类金属配位聚合物及其制法及应用
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US8633200B2
(en)
|
2010-09-08 |
2014-01-21 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
CN101993415B
(zh)
|
2010-09-15 |
2013-08-14 |
北京韩美药品有限公司 |
作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
|
WO2012047856A2
(en)
|
2010-10-04 |
2012-04-12 |
Institute For Hepatitis And Virus Research |
Novel inhibitors of secretion of hepatitis b virus antigens
|
EP2444084A1
(en)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Use of PI3K inibitors for the treatment of obesity
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
WO2012068406A2
(en)
|
2010-11-18 |
2012-05-24 |
Ligand Pharmaceuticals Incorporated |
Use of hematopoietic growth factor mimetics
|
WO2012080376A1
(en)
|
2010-12-17 |
2012-06-21 |
Syngenta Participations Ag |
Insecticidal compounds
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
2-芳基咪唑并[1,2-b]嗒.2-苯基咪唑并[1,2-a]吡啶,和2-苯基咪唑并[1,2-a]吡衍生物
|
KR20140027090A
(ko)
|
2011-01-04 |
2014-03-06 |
노파르티스 아게 |
연령-관련 황반 변성 (amd)의 치료에 유용한 인돌 화합물 또는 그의 유사체
|
US9018395B2
(en)
|
2011-01-27 |
2015-04-28 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
EP2685981B1
(en)
|
2011-03-17 |
2016-08-24 |
Bristol-Myers Squibb Company |
Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
WO2012139425A1
(en)
|
2011-04-13 |
2012-10-18 |
Schering Corporation |
5-substituted iminothiazines and their mono-and dioxides as bace inhibitors,compositions,and their use
|
CN102796103A
(zh)
|
2011-05-23 |
2012-11-28 |
南京英派药业有限公司 |
6-(芳基甲酰)咪唑并[1,2-a]嘧啶和6-(芳基甲酰)[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用
|
EP2713722B1
(en)
|
2011-05-31 |
2017-03-15 |
Receptos, LLC |
Novel glp-1 receptor stabilizers and modulators
|
GB201109763D0
(en)
|
2011-06-10 |
2011-07-27 |
Ucl Business Plc |
Compounds
|
WO2012175991A1
(en)
|
2011-06-24 |
2012-12-27 |
Pharminox Limited |
Fused pentacyclic anti - proliferative compounds
|
CA2841111A1
(en)
|
2011-07-08 |
2013-01-17 |
Novartis Ag |
Novel pyrrolo pyrimidine derivatives
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
WO2013033901A1
(en)
*
|
2011-09-08 |
2013-03-14 |
Merck Sharp & Dohme Corp. |
Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases
|
WO2013040528A1
(en)
|
2011-09-16 |
2013-03-21 |
Microbiotix, Inc. |
Antimicrobial compounds
|
WO2013043521A1
(en)
|
2011-09-22 |
2013-03-28 |
Merck Sharp & Dohme Corp. |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors
|
JP6040677B2
(ja)
*
|
2011-09-29 |
2016-12-07 |
東洋インキScホールディングス株式会社 |
太陽電池封止材用樹脂組成物
|
WO2013054291A1
(en)
|
2011-10-13 |
2013-04-18 |
Novartis Ag |
Novel oxazine derivatives and their use in the treatment of disease
|
CN103998451A
(zh)
|
2011-10-20 |
2014-08-20 |
葛兰素史密斯克莱有限责任公司 |
用作沉默调节蛋白调节剂的取代的双环氮杂杂环化合物和类似物
|
EP2768832A1
(en)
|
2011-10-21 |
2014-08-27 |
Torrent Pharmaceuticals Limited |
Novel substituted imidazopyrimidines as gpbar1 receptor modulators
|
WO2013120040A1
(en)
|
2012-02-10 |
2013-08-15 |
Children's Medical Center Corporation |
Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
JPWO2013133367A1
(ja)
|
2012-03-09 |
2015-07-30 |
カルナバイオサイエンス株式会社 |
新規トリアジン誘導体
|
WO2013157021A1
(en)
|
2012-04-20 |
2013-10-24 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
PE20141558A1
(es)
|
2012-04-20 |
2014-11-06 |
Gilead Sciences Inc |
Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
EP2862853B1
(en)
|
2012-06-18 |
2020-01-22 |
Sumitomo Chemical Co., Ltd |
Fused heterocyclic compound
|
WO2014007228A1
(ja)
|
2012-07-03 |
2014-01-09 |
小野薬品工業株式会社 |
ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
|
JP6259823B2
(ja)
|
2012-07-13 |
2018-01-10 |
ユーシービー バイオファルマ エスピーアールエル |
Tnf活性の調節物質としてのイミダゾピリジン誘導体
|
GB201212513D0
(en)
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|
JP2015178457A
(ja)
|
2012-07-25 |
2015-10-08 |
杏林製薬株式会社 |
ピラゾロピリジン誘導体、またはその薬理学的に許容される塩
|
EP2892899B1
(en)
|
2012-09-06 |
2018-03-21 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
EP2900657B1
(en)
|
2012-09-26 |
2020-03-11 |
F.Hoffmann-La Roche Ag |
Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
WO2014061693A1
(ja)
|
2012-10-17 |
2014-04-24 |
塩野義製薬株式会社 |
新規非芳香族炭素環又は非芳香族複素環誘導体
|
EP2922548A4
(en)
|
2012-11-21 |
2016-06-01 |
Stategics Inc |
SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROPOLATION, DIFFERENTIATION AND OVER LIVING
|
JP6037804B2
(ja)
|
2012-12-03 |
2016-12-07 |
富士フイルム株式会社 |
ガス分離膜
|
EA035929B1
(ru)
|
2013-01-15 |
2020-09-02 |
Инсайт Холдингс Корпорейшн |
ТИАЗОЛКАРБОКСАМИДЫ И ПИРИДИНКАРБОКСАМИДЫ, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Pim-КИНАЗЫ
|
CA2896185A1
(en)
|
2013-01-22 |
2014-07-31 |
F. Hoffmann-La Roche Ag |
Fluoro-[1,3]oxazines as bace1 inhibitors
|
CN103933036B
(zh)
|
2013-01-23 |
2017-10-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
2‑芳基咪唑并[1,2‑α]吡啶‑3‑乙酰胺衍生物在制备防治PTSD的药物中的用途
|
US9657082B2
(en)
|
2013-01-31 |
2017-05-23 |
Thomas Jefferson University |
PD-L1 and PD-L2-based fusion proteins and uses thereof
|
KR102169426B1
(ko)
|
2013-02-27 |
2020-10-23 |
모찌다 세이야쿠 가부시끼가이샤 |
신규 피라졸 유도체
|
KR20150124985A
(ko)
|
2013-03-08 |
2015-11-06 |
암젠 인크 |
베타-세크레타제 억제제로서 퍼플루오르화된 사이클로프로필 융합된 1,3-옥사진-2-아민 화합물 및 그의 사용 방법
|
AU2014231768A1
(en)
|
2013-03-13 |
2015-09-24 |
Australian Nuclear Science And Technology Organisation |
Transgenic non-human organisms with non-functional TSPO genes
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
DK2968304T3
(en)
|
2013-03-14 |
2019-01-28 |
Univ Columbia |
4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE.
|
CN105189503B
(zh)
|
2013-03-14 |
2017-03-22 |
百时美施贵宝公司 |
人免疫缺陷病毒复制的抑制剂
|
EP2968265A4
(en)
|
2013-03-14 |
2016-12-28 |
Celtaxsys Inc |
INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
|
MA38461B1
(fr)
|
2013-03-14 |
2021-10-29 |
Curadev Pharma Private Ltd |
Inhibiteurs de la voie de la kynurénine
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
ME03307B
(me)
|
2013-06-26 |
2019-10-20 |
Abbvie Inc |
Primarni karboksamidi kao btk inhibitori
|
WO2015000715A1
(en)
|
2013-07-02 |
2015-01-08 |
Syngenta Participations Ag |
Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
|
SG11201600108PA
(en)
|
2013-07-17 |
2016-02-26 |
Otsuka Pharma Co Ltd |
Cyanotriazole compounds
|
RU2016105108A
(ru)
|
2013-07-25 |
2017-08-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Ингибиторы факторов транскрипции и их применение
|
EP2835375A1
(en)
|
2013-08-09 |
2015-02-11 |
Fundació Institut Català d'Investigació Química |
Bis-salphen compounds and carbonaceous material composites comprising them
|
KR101715090B1
(ko)
|
2013-08-28 |
2017-03-13 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
ES2642074T3
(es)
*
|
2013-09-04 |
2017-11-15 |
Bristol-Myers Squibb Company |
Compuestos útiles como inmunomoduladores
|
ES2788848T3
(es)
|
2013-09-06 |
2020-10-23 |
Aurigene Discovery Tech Ltd |
Derivados de 1,2,4-oxadiazol como inmunomoduladores
|
PT3041828T
(pt)
|
2013-09-06 |
2018-10-09 |
Aurigene Discovery Tech Ltd |
Derivados 1,3,4-0xadiazoles como imonomoduladores
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
JP6336870B2
(ja)
|
2013-09-30 |
2018-06-06 |
日本ポリプロ株式会社 |
ビフェノール化合物及びそれを用いるオレフィン重合用触媒並びにオレフィン重合体の製造方法
|
FR3012140B1
(fr)
|
2013-10-18 |
2016-08-26 |
Arkema France |
Unite et procede pour la purification de methacrylate de methyle brut
|
GB201321733D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321736D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321746D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
GB201321743D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
WO2015095337A2
(en)
|
2013-12-18 |
2015-06-25 |
The Rockefeller University |
PYRAZOLO[1,5-a]PYRIMIDINECARBOXAMIDE DERIVATIVES FOR TREATING COGNITIVE IMPAIRMENT
|
ES2683693T3
(es)
|
2014-01-03 |
2018-09-27 |
Bayer Animal Health Gmbh |
Nuevas pirazolil-heteroarilamidas como agentes plaguicidas
|
US20160356794A1
(en)
|
2014-02-10 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
US9732103B2
(en)
|
2014-02-25 |
2017-08-15 |
Achillion Pharmaceuticals, Inc. |
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
|
US9394365B1
(en)
|
2014-03-12 |
2016-07-19 |
Yeda Research And Development Co., Ltd |
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
|
JP6490464B2
(ja)
|
2014-03-26 |
2019-03-27 |
三井化学株式会社 |
遷移金属化合物、オレフィン重合用触媒およびオレフィン系重合体の製造方法
|
EP3125883B1
(en)
|
2014-04-04 |
2020-08-12 |
Iomet Pharma Ltd. |
Indole derivatives for use in medicine
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
WO2015197028A1
(en)
*
|
2014-06-28 |
2015-12-30 |
Sunshine Lake Pharma Co., Ltd. |
Compounds as hepatitis c virus (hcv) inhibitors and uses thereof in medicine
|
CN104211726B
(zh)
|
2014-08-11 |
2017-06-16 |
中南民族大学 |
非茂类三齿双核钛配合物、制备方法及用途
|
EP3193608A4
(en)
|
2014-09-17 |
2018-05-02 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
WO2016041511A1
(en)
|
2014-09-19 |
2016-03-24 |
Yen-Ta Lu |
Benzo-heterocyclic compounds and their applications
|
SG11201701573QA
(en)
|
2014-10-06 |
2017-03-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
AU2015360416A1
(en)
|
2014-12-10 |
2017-06-08 |
Massachusetts Institute Of Technology |
Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
|
JP6853619B2
(ja)
|
2015-01-16 |
2021-03-31 |
大塚製薬株式会社 |
シアノトリアゾール化合物の医薬用途
|
US10071998B2
(en)
|
2015-01-20 |
2018-09-11 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use
|
DE112016000383A5
(de)
|
2015-01-20 |
2017-10-05 |
Cynora Gmbh |
Organische Moleküle, insbesondere zur Verwendung in optoelektronischen Bauelementen
|
WO2016156282A1
(en)
|
2015-04-02 |
2016-10-06 |
Bayer Cropscience Aktiengesellschaft |
Novel triazole compounds for controlling phytopathogenic harmful fungi
|
WO2017035405A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Amino compounds for treatment of immune and inflammatory disorders
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
MA52119A
(fr)
|
2015-10-19 |
2018-08-29 |
Ncyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2017070320A1
(en)
|
2015-10-21 |
2017-04-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Phenyl indole allosteric inhibitors of p97 atpase
|
KR101717601B1
(ko)
|
2015-11-10 |
2017-03-20 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
SG11201804152RA
(en)
|
2015-11-19 |
2018-06-28 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
AU2016378482A1
(en)
|
2015-12-22 |
2018-07-12 |
Synthon B.V. |
Pharmaceutical composition comprising amorphous lenalidomide and an antioxidant
|
JP6943857B2
(ja)
|
2015-12-22 |
2021-10-06 |
シンジェンタ パーティシペーションズ アーゲー |
有害生物防除活性ピラゾール誘導体
|
SG10202111399YA
(en)
|
2015-12-22 |
2021-11-29 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
WO2017107052A1
(en)
|
2015-12-22 |
2017-06-29 |
Merck Sharp & Dohme Corp. |
Soluble guanylate cyclase stimulators
|
EP4292650A3
(en)
|
2015-12-22 |
2024-02-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
KR101653560B1
(ko)
|
2016-02-02 |
2016-09-12 |
한국화학연구원 |
신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
|
AR109452A1
(es)
|
2016-04-22 |
2018-12-12 |
Incyte Corp |
Formulación farmacéutica de un inhibidor de lsd1 y método de tratamiento
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
MX2018016331A
(es)
|
2016-06-20 |
2019-05-20 |
Novartis Ag |
Formas cristalinas de compuesto de triazolopirimidina.
|
CN109641034B
(zh)
|
2016-06-20 |
2023-08-15 |
伊兰科美国公司 |
聚乙二醇化的猪干扰素及其使用方法
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
JP7054529B2
(ja)
|
2016-06-21 |
2022-04-14 |
エックス4 ファーマシューティカルズ, インコーポレイテッド |
Cxcr4阻害剤およびその使用
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
CA3030773A1
(en)
*
|
2016-08-03 |
2018-02-08 |
Arising International, Inc. |
Symmetric or semi-symmetric compounds useful as immunomodulators
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
SG11201901390TA
(en)
|
2016-08-30 |
2019-03-28 |
Tetraphase Pharmaceuticals Inc |
Tetracycline compounds and methods of treatment
|
JP7022131B2
(ja)
|
2016-12-21 |
2022-02-17 |
アセルタ ファーマ ビー.ブイ. |
ブルトン型チロシンキナーゼのイミダゾピラジン阻害剤
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
AU2017382405B2
(en)
|
2016-12-22 |
2021-12-16 |
Calithera Biosciences, Inc. |
Compositions and methods for inhibiting arginase activity
|
PL3558990T3
(pl)
|
2016-12-22 |
2022-12-19 |
Incyte Corporation |
Pochodne tetrahydroimidazo[4,5-c]pirydyny jako induktory internalizacji pd-l1
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10308644B2
(en)
|
2016-12-22 |
2019-06-04 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
CA3070794A1
(en)
|
2017-07-28 |
2019-01-31 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
EP3664793B1
(en)
|
2017-08-08 |
2022-06-29 |
ChemoCentryx, Inc. |
Macrocyclic immunomodulators
|
EP3669872A4
(en)
|
2017-08-18 |
2021-05-05 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
FORMYL PYRIDINE DERIVATIVE WITH PD-L1 INHIBITORING EFFECT, MANUFACTURING METHOD FOR IT AND USE THEREOF
|
WO2019191707A1
(en)
|
2018-03-30 |
2019-10-03 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
JP2021520342A
(ja)
|
2018-04-03 |
2021-08-19 |
ベータ ファーマシューティカルズ カンパニー リミテッド |
免疫調節物質、組成物及びそれらの方法
|
JP7242702B2
(ja)
|
2018-04-19 |
2023-03-20 |
ギリアード サイエンシーズ, インコーポレイテッド |
Pd-1/pd-l1阻害剤
|
DK3790877T3
(da)
|
2018-05-11 |
2023-04-24 |
Incyte Corp |
Tetrahydro-imidazo[4,5-c]pyridinderivater som pd-l1-immunmodulatorer
|
KR102635333B1
(ko)
|
2018-10-24 |
2024-02-15 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
JP2022513592A
(ja)
|
2018-11-02 |
2022-02-09 |
シャンハイ マキシノベル ファーマシューティカルズ カンパニー リミテッド |
ビフェニル系化合物、その中間体、製造方法、医薬組成物及び使用
|
CN113365995A
(zh)
|
2019-01-31 |
2021-09-07 |
贝达药业股份有限公司 |
免疫调节剂,组合物及其方法
|
US11753406B2
(en)
|
2019-08-09 |
2023-09-12 |
Incyte Corporation |
Salts of a PD-1/PD-L1 inhibitor
|
KR20220075382A
(ko)
|
2019-09-30 |
2022-06-08 |
인사이트 코포레이션 |
면역조절제로서의 피리도[3,2-d]피리미딘 화합물
|
BR112022009031A2
(pt)
|
2019-11-11 |
2022-10-11 |
Incyte Corp |
Sais e formas cristalinas de um inibidor de pd-1/pd-l1
|
WO2022099018A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Process of preparing a pd-1/pd-l1 inhibitor
|
AU2021373044A1
(en)
|
2020-11-06 |
2023-06-08 |
Incyte Corporation |
Process for making a pd-1/pd-l1 inhibitor and salts and crystalline forms thereof
|
TW202233615A
(zh)
|
2020-11-06 |
2022-09-01 |
美商英塞特公司 |
Pd—1/pd—l1抑制劑之結晶形式
|
TW202241420A
(zh)
|
2020-12-18 |
2022-11-01 |
美商英塞特公司 |
Pd-l1抑制劑之口服調配物
|